NCT06614049
- Conditions
- Behavior, Dyslipidemias, Health Behavior, +10 more
- Locations
-
- National Healthcare Group Polyclinics Singapore
- National University Polyclinics Singapore
Clinical trial condition
Hyperlipidemia
Explore clinical trials studying Hyperlipidemia. Study availability and eligibility vary by location and protocol.
341 public trials
22 recruiting studies
Hyperlipidemia trial results
NCT06503172
- Conditions
- Atrophy, Dyslipidemias, Frailty, +16 more
- Locations
-
- Taipei Veterans General hospital Taipei, Taiwan
Enrolling by Invitation
Effect of Smartphone Application (MED-AD) on Medication Adherence Among Patients With Cardiovascular Disease in Oman
NCT06951451
- Conditions
- Cardiovascular Diseases, Dyslipidemias, Hyperlipidemia, +7 more
- Locations
-
- Ministry of Health Muscat, Oman
Enrolling by Invitation
Evaluating the Effectiveness of a Multi-level Health-Related Social Needs Initiative
NCT06831162
- Conditions
- Cardiovascular Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 2, +12 more
- Locations
-
- Vanderbilt University Medical Center Nashville, Tennessee, United States
Enrolling by Invitation
Truway Diagnostic Tools in Primary Care
NCT07209527
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +42 more
- Locations
-
- Truway Health, Inc. New York, United States
Enrolling by Invitation
LORLATINIB-related HYPERLIPIDEMIA in ALK+ Non-Small Cell Lung Cancer
NCT06876675
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +14 more
- Locations
-
- Peking University Third Hospital Beijing, China
Enrolling by Invitation
Study on the Sex-specific, Lipid- and Lipoprotein-lowering Effects of Berberine
NCT06782646
- Conditions
- Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
- Locations
-
- School of Public Health, The University of Hong Kong Hong Kong
Not Yet Recruiting
A Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-236A and AD-236B
NCT07730567
- Conditions
- Diabete Type 2, Diabetes Mellitus, Diabetes Mellitus, Type 2, +8 more
- Locations
-
- H+ Yangji Hospital, Seoul, Seoul, South Korea
Not Yet Recruiting
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAL0167 in Healthy Participants
NCT07722299
- Conditions
- Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
- Locations
-
- Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China
Not Yet Recruiting
Tafolecimab in Hyperlipidemia: A Study of Different Dosing Intervals
NCT07712042
- Conditions
- Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
- Locations
-
- Qianfoshan Hospital Ji'nan, China